Clinical Trials Browser

Hyperthermia, Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT03651375 2021-01-22

UN-RESARC

Phase 2 Unknown

46 enrolled

Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Lymphangiosarcoma, Myosarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Histiocytic Sarcoma

NCT04606108 2020-10-28

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma

Phase 2 Unknown

62 enrolled

Sarcoma

NCT04356872 2020-07-14

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

Phase 2 Unknown

45 enrolled

Sarcoma

NCT04447274 2020-06-25

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

Phase 2 Unknown

20 enrolled

Sarcoma

NCT03268772 2020-04-22

PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS

Phase 2 Unknown

40 enrolled

Sarcoma

NCT04239443 2020-01-27

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Phase 2 Unknown

120 enrolled

GynecologicSarcoma

Sarcoma, Uterine Neoplasms

NCT04126811 2019-10-15

Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma

Phase 2 Unknown

120 enrolled

Sarcoma

NCT04126993 2019-10-15

Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma

Phase 2 Unknown

80 enrolled

Sarcoma

NCT03946943 2019-07-10

Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

Phase 2 Unknown

25 enrolled

Sarcoma

Sarcoma, Histiocytoma, Malignant Fibrous

NCT03815474 2019-07-09

ALTER-S005

Phase 2 Unknown

47 enrolled

Sarcoma

NCT03816475 2019-06-17

LIPOMYX

Phase 2 Unknown

35 enrolled

Sarcoma

Sarcoma, Liposarcoma, Myxoid

NCT03880695 2019-03-21

ALTER-S001

Phase 2 Unknown

48 enrolled

Sarcoma

NCT01337401 2019-01-24

CASPS

Phase 2 Unknown

36 enrolled

Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

NCT03792542 2019-01-03

Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy

Phase 2 Unknown

44 enrolled

Sarcoma

NCT01552239 2018-10-16

PREMISS

Phase 2 Unknown

50 enrolled

Sarcoma

NCT01807468 2018-09-18

Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors

Phase 2 Unknown

12 enrolled

CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT03539172 2018-05-30

RASS

Phase 2 Unknown

61 enrolled

Head & NeckSarcoma

Head and Neck Neoplasms, Sarcoma, Neoplasms, Connective and Soft Tissue

NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Phase 2 Unknown

60 enrolled

GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

NCT03096912 2017-10-25

A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Phase 2 Unknown

30 enrolled

Sarcoma

Lipoma, Liposarcoma, Sarcoma, Liposarcoma, Myxoid

NCT03121846 2017-05-22

Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy

Phase 2 Unknown

80 enrolled

Sarcoma

NCT03064243 2017-02-27

A Phase II Study of Apatinib in STS Patients

Phase 2 Unknown

53 enrolled

Sarcoma

NCT02571829 2016-11-23

A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Phase 2 Unknown

30 enrolled

Sarcoma

Liposarcoma, Sarcoma

NCT02812654 2016-06-24

Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment

Phase 2 Unknown

70 enrolled

Sarcoma

NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Phase 2 Unknown

35 enrolled

Sarcoma

Recurrence, Sarcoma

NCT00410462 2014-08-08

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Phase 2 Unknown

118 enrolled

GynecologicSarcoma

Malignant mesenchymal tumor, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00718484 2014-01-30

PICASSO

Phase 2 Unknown

67 enrolled

Sarcoma

NCT00084695 2014-01-10

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

Phase 2 Unknown

25 enrolled

CNSClassical hematologyLymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fanconi Anemia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Recurrence, Sarcoma, Leukemia, Myeloid, Chronic-Phase, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

NCT00003718 2014-01-06

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2 Unknown

25 enrolled

GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00003719 2014-01-06

Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma

Phase 2 Unknown

27 enrolled

Sarcoma

NCT00017446 2014-01-06

CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Phase 2 Unknown

Sarcoma

Clinical Trials

Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.

PalboSarc

Chidamide Combined With Toripalimab in Sarcoma

Phase II Study of TAEST16001 in Soft Tissue Sarcoma

Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma

Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma

Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma

Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma

SYNERGIAS

HyperTET

Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma

Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma

Fruquintinib in the Treatment of Soft Tissue Sarcoma

A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma

A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma

DOREMY

Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma

Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma

SINDIR

UN-RESARC

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma

Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma

Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

ALTER-S005

LIPOMYX

ALTER-S001

CASPS

Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy

PREMISS

Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors

RASS

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy

A Phase II Study of Apatinib in STS Patients

A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

PICASSO

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma

CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma